Skip to main content

Advertisement

Log in

MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Post-traumatic hypertrophic scar (HS) is a fibrotic disease with excessive extracellular matrix (ECM) production, which is a response to tissue injury by fibroblasts. Although emerging evidence has indicated that miRNA contributes to hypertrophic scarring, the role of miRNA in HS formation remains unclear. In this study, we found that miR-143-3p was markedly downregulated in HS tissues and fibroblasts (HSFs) using qRT-PCR. The expression of connective tissue growth factor (CTGF/CCN2) was upregulated both in HS tissues and HSFs, which is proposed to play a key role in ECM deposition in HS. The protein expression of collagen I (Col I), collagen III (Col III), and α-smooth muscle actin (α-SMA) was obviously inhibited after treatment with miR-143-3p in HSFs. The CCK-8 assay showed that miR-143-3p transfection reduced the proliferation ability of HSFs, and flow cytometry showed that either early or late apoptosis of HSFs was upregulated by miR-143-3p. In addition, the activity of caspase 3 and caspase 9 was increased after miR-143-3p transfection. On the contrary, the miR-143-3p inhibitor was demonstrated to increase cell proliferation and inhibit apoptosis of HSFs. Moreover, miR-143-3p targeted the 3′-UTR of CTGF and caused a significant decrease of CTGF. Western blot demonstrated that Akt/mTOR phosphorylation and the expression of CTGF, Col I, Col III, and α-SMA were inhibited by miR-143-3p, but increased by CTGF overexpression. In conclusion, we found that miR-143-3p inhibits hypertrophic scarring by regulating the proliferation and apoptosis of human HSFs, inhibiting ECM production-associated protein expression by targeting CTGF, and restraining the Akt/mTOR pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Gauglitz GG, Korting HC, Pavicic T et al (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17:113–125

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Sidgwick GP, Iqbal SA, Bayat A (2013) Altered expression of hyaluronan synthase and hyaluronidase mRNA may affect hyaluronic acid distribution in keloid disease compared with normal skin. Exp Dermatol 22:377–379

    Article  CAS  PubMed  Google Scholar 

  3. Meyer LJ, Russell SB, Russell JD et al (2000) Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. J Invest Dermatol 114:953–959

    Article  CAS  PubMed  Google Scholar 

  4. Syed F, Ahmadi E, Iqbal SA et al (2011) Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy. Br J Dermatol 164:83–96

    Article  CAS  PubMed  Google Scholar 

  5. Kashiyama K, Mitsutake N, Matsuse M et al (2012) miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts. J Invest Dermatol 132:1597–1604

    Article  CAS  PubMed  Google Scholar 

  6. Li P, He QY, Luo CQ (2014) Overexpression of miR-200b inhibits the cell proliferation and promotes apoptosis of human hypertrophic scar fibroblasts in vitro. J Dermatol 41:903–911

    Article  CAS  PubMed  Google Scholar 

  7. He L, He X, Lim LP et al (2007) A microRNA component of the p53 tumour suppressor network. Nature 447:1130–1134

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Yi R, O’Carroll D, Pasolli HA et al (2006) Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat Genet 38:356–362

    Article  CAS  PubMed  Google Scholar 

  9. Baek D, Villen J, Shin C et al (2008) The impact of microRNAs on protein output. Nature 455:64–71

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23:175–205

    Article  CAS  PubMed  Google Scholar 

  11. Liang P, Lv C, Jiang B et al (2012) MicroRNA profiling in denatured dermis of deep burn patients. Burns 38:534–540

    Article  PubMed  Google Scholar 

  12. Chau BN, Brenner DA (2011) What goes up must come down: the emerging role of microRNA in fibrosis. Hepatology 53:4–6

    Article  CAS  PubMed  Google Scholar 

  13. Shi-Wen X, Leask A, Abraham D (2008) Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 19:133–144

    Article  PubMed  Google Scholar 

  14. Jun JI, Lau LF (2011) Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov 10:945–963

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ivkovic S, Yoon BS, Popoff SN et al (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130:2779–2791

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Duisters RF, Tijsen AJ, Schroen B et al (2009) miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 104:170–178 (176 p following 178)

  17. Browne JG, Ho SL, Kane R et al (2011) Connective tissue growth factor is increased in pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 52:3660–3666

    Article  CAS  PubMed  Google Scholar 

  18. Ponticos M, Holmes AM, Shi-wen X et al (2009) Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis Rheum 60:2142–2155

    Article  CAS  PubMed  Google Scholar 

  19. Khoo YT, Ong CT, Mukhopadhyay A et al (2006) Upregulation of secretory connective tissue growth factor (CTGF) in keratinocyte-fibroblast coculture contributes to keloid pathogenesis. J Cell Physiol 208:336–343

    Article  CAS  PubMed  Google Scholar 

  20. Arakawa M, Hatamochi A, Takeda K et al (1990) Increased collagen synthesis accompanying elevated m-RNA levels in cultured Werner’s syndrome fibroblasts. J Invest Dermatol 94:187–190

    Article  CAS  PubMed  Google Scholar 

  21. Babalola O, Mamalis A, Lev-Tov H et al (2013) The role of microRNAs in skin fibrosis. Arch Dermatol Res 305:763–776

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Li C, Bai Y, Liu H et al (2013) Comparative study of microRNA profiling in keloid fibroblast and annotation of differential expressed microRNAs. Acta Biochim Biophys Sin (Shanghai) 45:692–699

    Article  CAS  Google Scholar 

  23. Zhou P, Chen WG, Li XW (2015) MicroRNA-143 acts as a tumor suppressor by targeting hexokinase 2 in human prostate cancer. Am J Cancer Res 5:2056–2063

    PubMed  PubMed Central  Google Scholar 

  24. Zhou R, Zhang Q, Zhang Y et al (2015) Aberrant miR-21 and miR-200b expression and its pro-fibrotic potential in hypertrophic scars. Exp Cell Res 339(2):360–366

    Article  CAS  PubMed  Google Scholar 

  25. Fuchshofer R, Ullmann S, Zeilbeck LF et al (2011) Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury. Histochem Cell Biol 136:301–319

    Article  CAS  PubMed  Google Scholar 

  26. Abreu JG, Ketpura NI, Reversade B et al (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4:599–604

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Li C, Zhu HY, Bai WD et al (2015) MiR-10a and miR-181c regulate collagen type I generation in hypertrophic scars by targeting PAI-1 and uPA. FEBS Lett 589:380–389

    Article  CAS  PubMed  Google Scholar 

  28. Lu Q, Zuo WZ, Ji XJ et al (2015) Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis through Akt/mTOR signaling in diabetic nephropathy. Phytomedicine 22:1071–1078

    Article  CAS  PubMed  Google Scholar 

  29. Phanish MK, Winn SK, Dockrell ME (2010) Connective tissue growth factor-(CTGF, CCN2)—a marker, mediator and therapeutic target for renal fibrosis. Nephron Exp Nephrol 114:e83–e92

    Article  CAS  PubMed  Google Scholar 

  30. Tsang M, Leask A (2015) CCN2 is required for recruitment of Sox2-expressing cells during cutaneous tissue repair. J Cell Commun Signal 9:341–346

    Article  PubMed  PubMed Central  Google Scholar 

  31. Teng Y, Zhang R, Liu C et al (2015) miR-143 inhibits interleukin-13-induced inflammatory cytokine and mucus production in nasal epithelial cells from allergic rhinitis patients by targeting IL13Rα1. Biochem Biophys Res Commun 457:58–64

    Article  CAS  PubMed  Google Scholar 

  32. Wang H, Chen Z, Li XJ et al (2015) Anti-inflammatory cytokine TSG-6 inhibits hypertrophic scar formation in a rabbit ear model. Eur J Pharmacol 751:42–49

    Article  CAS  PubMed  Google Scholar 

  33. Cooker LA, Peterson D, Rambow J et al (2007) TNF-alpha, but not IFN-gamma, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis. Am J Physiol Renal Physiol 293:F157–F165

    Article  CAS  PubMed  Google Scholar 

  34. Lee CH, Shah B, Moioli EK et al (2015) CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J Clin Invest 125:3992

    Article  PubMed  PubMed Central  Google Scholar 

  35. Li D, Wang A, Liu X et al (2015) MicroRNA-132 enhances transition from inflammation to proliferation during wound healing. J Clin Invest 125:3008–3026

    Article  PubMed  PubMed Central  Google Scholar 

  36. Fernandes T, Barauna VG, Negrao CE et al (2015) Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs. Am J Physiol Heart Circ Physiol 309:H543–H552

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Weihui Zeng.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mu, S., Kang, B., Zeng, W. et al. MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway. Mol Cell Biochem 416, 99–108 (2016). https://doi.org/10.1007/s11010-016-2699-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-016-2699-9

Keywords

Navigation